From: Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions
Samples
IC50 (μM)
RHE
DOX
73.86 ± 4.40
–
1.30 ± 0.22
RHE/DOX
2.53 ± 0.43
0.84 ± 0.16
RD NPs
1.88 ± 0.60
0.63 ± 0.23